GENEVA, Aug. 10 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No. 7 Kunlunshan Road, Economic And Technological Development Zone,Lianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号) filed a patent application (PCT/CN2025/075142) for "ANTI-CD79B ANTIBODY-DRUG CONJUGATE COMBINED WITH IMMUNOTHERAPEUTIC AGENT AND CHEMOTHERAPEUTIC AGENT FOR TREATING TUMOR" on Jan 26, 2025. With publication no. WO/2025/162364, the details related to the patent application was published on Aug 07, 2025.
Notably, the paten...